Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ASNS pseudogene 6 (ASNSP6) is a pseudogene—a nonfunctional remnant of the ASNS (asparagine synthetase) gene. Pseudogenes like ASNSP6 are DNA sequences that closely resemble protein-coding genes but have lost their protein-coding potential due to mutations or lack of proper regulatory elements. ASNSP6 does not produce a functional enzyme or protein and does not have an established role in any biological process, disease, or as a therapeutic target. Pseudogenes may occasionally be transcribed, but their RNA products are generally considered biologically inert, although rare regulatory roles have been described for some pseudogenes. ASNSP6 is not considered druggable, is not implicated as a disease gene, and has no known pharmacological or biomarker relevance[5][7][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ASNS pseudogene 6 (ASNSP6).